At Intelerad, our mission is to improve global human health. Breast Cancer Awareness Month supports the promotion of screening and prevention of cancer, which *impacts one in eight women in the United States every year and 2.3 million women worldwide.
Learn more about the power of our solutions and how they’re empowering physicians to drive better care outcomes.
*This information is provided by Breastcancer.org.
This partnership strengthens clinical decision-making, increases operational efficiencies, reduces costs, and improves mammography quality and mammography facility adherence with MQSA EQUIP standards.
PenRad MIS significantly improves professional productivity, quality and revenue in the mammography reporting workflow. Through Automatic Reporting, PenRad provides the tracking of breast density, risk assessment scoring, genetic assessment and the intake of patient clinical and family history. Screening for breast cancer and awaiting one’s results can be a distressful process. Reduce anxiety and improve your patients’ experience with PenRad by easily sending their results by email once their exam has been read.
Conflicting advice from medical professionals and delayed preventative care during the pandemic created a perfect storm that put potentially millions of women at risk of delayed diagnosis, serious complications and death related to breast cancer.
Raising and maintaining awareness about breast cancer is an important mission. To achieve the greater aims of better preventing, diagnosing, and treating breast cancer, promoting awareness must be paired with encouraging action by patients and practitioners.
Learn more about how Intelerad strives to be at the forefront of breast imaging technology to improve the wellbeing and quality of life for all patients.